Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

First clinical data presented for first-in-class NOTCH inhibitor CB-103

Sep. 23, 2020

REVOLUTION Medicines patents SOS1 inhibitors

Sep. 23, 2020

Cyteir Therapeutics describes RAD51A inhibitors

Sep. 23, 2020

Phase I data for sotorasib in advanced solid tumors harboring the KRAS p.G12C mutation

Sep. 23, 2020

First-in-human study of IGM-8444 begins in patients with solid tumors

Sep. 23, 2020

HanX begins phase I trial in China with ON-123300

Sep. 22, 2020

Discovery of novel selective HDAC6-selective inhibitor, PTG-0861

Sep. 22, 2020

Metastatic migration is collective effort for colorectal cancers

Sep. 22, 2020

New compounds for cancer presented by Virginia Commonwealth University

Sep. 22, 2020

Silverback Therapeutics identifies TGFBR inhibitors

Sep. 22, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...